Skip to market wire
Back to Market返回行情

0546.HK Fufeng Group Limited

HKSEBasic Materials
HK$5.22+2.35%LatestMarket Cap: HK$13.09B

As of 2026-08-28 16:08

Why 0546.HK matters now

Fufeng Group Limited (0546.HK) is a Hong Kong stock in Basic Materials. The latest InvestLog snapshot shows HK$5.22 with +2.35% on the session and HK$13.09B in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 4.57, gross margin 19.7%, and operating margin 9.8%.

InvestLog's latest related AI research is a Earnings Release note titled "Fufeng Group Limited (0546.HK) 2026 H1 financial results".

Valuation

P/E (TTM)

4.57

PEG

P/B

0.58

P/S

0.40

EV/EBITDA

2.63

DCF Value

FCF Yield

8.9%

Div Yield

9.3%

Margins & Returns

Gross Margin

19.7%

Operating Margin

9.8%

Net Margin

8.8%

ROE

12.6%

ROA

5.6%

ROIC

5.7%

Listing Info

Market

Hong Kong

Exchange

HKSE

Currency

HKD

Sector

Basic Materials

Industry

Chemicals - Specialty

Country

CN

Fufeng Group Limited, an investment holding company, specializes in the global production and distribution of fermentation-based food additives, biochemicals, and starch-derived products, operating across markets in the People's Republic of China and internationally. Its business is structured into several key segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and an encompassing 'Other' segment. The Food Additives division is responsible for manufacturing and selling items such as monosodium glutamate (MSG), starch sweeteners, glutamic acid, compound seasonings, and corn oil. The Animal Nutrition segment focuses on producing and selling refined corn products, threonine, and lysine. High-end amino acids are offered through its dedicated segment, while the Colloid segment provides specialty gums like xanthan and gellan gum. The 'Other' segment encompasses a diverse range of products, including fertilizers, synthetic ammonia, and pharmaceuticals. Beyond these core activities, Fufeng Group is also engaged in the manufacturing and sale of construction materials such as autoclaved aerated concrete blocks and bricks, alongside eubacteria material medicine and various preparations. The company actively invests in the research, development, promotion, and industrialization of innovative biological techniques and their resultant achievements. Furthermore, it deals in cosmetics, biological products, and health foods, while also offering logistics, equity investment, and biological technique information services. Fufeng Group Limited was founded in 1999 and is headquartered in Linyi, People's Republic of China.